ASCO Presentation of Agenus’ AGEN1181 by Dr. Steven O’Day
LEXINGTON, Mass., May 29, 2020 /PRNewswire/ — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infections, announced the American Society of Clinical Oncology (ASCO2020) Virtual Scientific…
Comments Off on ASCO Presentation of Agenus’ AGEN1181 by Dr. Steven O’Day